Evidence map›Paper›PMID 31216762›Full record

ReviewMolecules (Basel, Switzerland)2019

Cinnoline Scaffold-A Molecular Heart of Medicinal Chemistry?

Marta Szumilak, Andrzej Stanczak

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Azo-Povarov Cycloaddition ofThe Journal of organic chemistry · 2026
    Article
  2. Review
  3. Steric Effects ofMolecules (Basel, Switzerland) · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. The pyridazine heterocycle in molecular recognition and drug discovery.Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2023
    Review
  8. Sc(OTf)The Journal of organic chemistry · 2022
    Article
  9. Article
  10. Article
  11. Review
  12. Heterocycles in Medicinal Chemistry.Molecules (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marta SzumilakDepartment of Hospital Pharmacy, Faculty of Pharmacy, Medical University of Lodz, 1 Muszynskiego Street, 90-151 Lodz, Poland. marta.szumilak@umed.lodz.pl.ORCID 0000-0001-7562-8933
Andrzej StanczakDepartment of Applied Pharmacy, Faculty of Pharmacy, Medical University of Lodz, 1 Muszynskiego Street, 90-151 Lodz, Poland. andrzej.stanczak@umed.lodz.pl.

Funding

Uniwersytet Medyczny w Lodzi 503-03/3-011-03/503-31-001 and 503/3-011-03/503-36-001
6 · The paper itself

Abstract

The cinnoline nucleus is a very important bicyclic heterocycle that is used as the structural subunit of many compounds with interesting pharmaceutical properties. Cinnoline derivatives exhibit broad spectrum of pharmacological activities such as antibacterial, antifungal, antimalarial, anti-inflammatory, analgesic, anxiolytic and antitumor activities. Some of them are under evaluation in clinical trials. In the present review, we have compiled studies focused on the biological properties of cinnoline derivatives conducted by many research groups worldwide between 2005 and 2019. Comprehensive and target oriented information clearly indicate that the development of cinnoline based molecules constitute a significant contribution to the identification of lead compounds with optimized pharmacodynamic and pharmacokinetic properties.

Indexed as

AnimalsAnti-Infective AgentsAntiparkinson AgentsChemistry, PharmaceuticalHeterocyclic Compounds, 2-RingHumansMolecular StructureProtein Kinase InhibitorsStructure-Activity RelationshipAnti-Infective AgentsAntiparkinson AgentscinnolineHeterocyclic Compounds, 2-RingProtein Kinase Inhibitorsbiological activitycinnolineheterocyclic compounds

Identifiers

PMID31216762
PMCPMC6631947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.